Get the Stockscreener App
10.21
0.87%
-0.09
Brainsway Ltd Adr stock is traded at $10.21, with a volume of 47,692.
It is down -0.87% in the last 24 hours and down -7.35% over the past month.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
See More
Previous Close:
$10.30
Open:
$10.18
24h Volume:
47,692
Relative Volume:
0.72
Market Cap:
$192.23M
Revenue:
$38.63M
Net Income/Loss:
$1.50M
P/E Ratio:
108.27
EPS:
0.0943
Net Cash Flow:
$5.97M
1W Performance:
+11.34%
1M Performance:
-7.35%
6M Performance:
+24.21%
1Y Performance:
+67.93%
1-Day Range:
$9.80
$10.38
1-Week Range:
$8.8762
$10.54
52-Week Range:
$4.61
$11.79
Brainsway Ltd Adr Stock (BWAY) Company Profile
Compare BWAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BWAY
Brainsway Ltd Adr
|
10.21 | 192.23M | 38.63M | 1.50M | 5.97M | 0.0943 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Brainsway Ltd Adr Stock (BWAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-16-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-03-22 | Initiated | Loop Capital | Buy |
| Jul-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-20-21 | Initiated | Northland Capital | Outperform |
| May-13-19 | Initiated | Cantor Fitzgerald | Overweight |
| May-13-19 | Initiated | Ladenburg Thalmann | Buy |
| May-13-19 | Initiated | Oppenheimer | Outperform |
| May-13-19 | Initiated | Raymond James | Outperform |
View All
Brainsway Ltd Adr Stock (BWAY) Latest News
BWAY Drops 15% in Four Days: How to Play the Stock Before Earnings? - Yahoo Finance
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why - Nasdaq
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Zacks.com Highlights: SB Financial Group, First Community, StoneX Group, Byrna Technologies, and BrainsWay - The Union Journal
Zacks.com featured highlights include SB Financial Group, First Community, StoneX Group, Byrna Technologies and BrainsWay - Yahoo Finance
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Zacks.com featured highlights include Mission Produce, Accel Entertainment, BrainsWay and First Bank - Yahoo Finance
Zacks.com featured highlights include Bridgewater Bancshares, Eastern Bankshares and BrainsWay - Yahoo Finance
Outbrain (OB) and Brainsway (BWAY) Are Aggressive Growth Stocks - Nasdaq
Outbrain (OB) And Brainsway (BWAY) Are Aggressive Growth Stocks - Barchart
Brainsway Ltd. Sponsored ADR (BWAY) Soars to 52-Week High, Time to Cash Out? - MSN
Brainsway (BWAY) Moves 8.0% Higher: Will This Strength Last? - MSN
Bear of the Day: Baxter (BAX) - Yahoo Finance
Wall Street Analysts Think Brainsway (BWAY) Could Surge 38.83%: Read This Before Placing a Bet - MSN
New Strong Buy Stocks for January 14th - MSN
Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why - Yahoo Finance
Earnings Estimates Rising for Brainsway (BWAY): Will It Gain? - MSN
Are Medical Stocks Lagging Brainsway (BWAY) This Year? - Yahoo Finance
Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock? - MSN
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy - GlobeNewswire Inc.
Brainsway stock soars to 52-week high, hits $10.75 - Investing.com
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024 - Yahoo Finance
Brainsway LtdADR (BWAY) Price Target Increased by 16.24% to 0.07 - MSN
Wall Street Analysts Believe Brainsway (BWAY) Could Rally 32.01%: Here's is How to Trade - MSN
Here's Why Momentum in Brainsway (BWAY) Should Keep going - MSN
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Brainsway stock soars to 52-week high, hits $10.01 - Investing.com
BrainsWay expands mental health treatment in East Asia - Investing.com India
Brainsway Stock Hits 52-Week High at $9.72 Amidst 143% Annual Surge - Investing.com
Does Brainsway (BWAY) Have the Potential to Rally 34.38% as Wall Street Analysts Expect? - MSN
Brainsway Ltd Adr Stock (BWAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):